Wade, you have judgement problem: ex. IART's Boston Factory product revenue was merely 4-5% of its total revenue, before and during the FDA inquiry and investigation period, yet you made the big deal of it. IART's stock decline has other reasons.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.